Chinas CNOOC, French energy firm Engie complete yuan-settled ... - Marketscreener.com
| 688277 Stock | 9.07 0.49 5.13% |
About 61% of Tinavi Medical's investor base is looking to short. The analysis of overall sentiment of trading Tinavi Medical Technologies stock suggests that many investors are alarmed at this time. The current market sentiment, together with Tinavi Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Tinavi Medical Techn stock news signals to limit their universe of possible portfolio assets.
Tinavi |
Chinas CNOOC, French energy firm Engie complete yuan-settled ... Marketscreener.com
Read at news.google.com
 |
Tinavi Medical Fundamental Analysis
We analyze Tinavi Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tinavi Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tinavi Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Tinavi Medical is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Tinavi Medical Techn Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tinavi Medical stock to make a market-neutral strategy. Peer analysis of Tinavi Medical could also be used in its relative valuation, which is a method of valuing Tinavi Medical by comparing valuation metrics with similar companies.
Peers
Tinavi Medical Related Equities
| 301301 | Yili Chuanning | 0.34 |
| ||
| 688363 | Bloomage Biotechnology | 2.06 |
| ||
| 000900 | Xiandai Investment | 2.33 |
| ||
| 600805 | Jiangsu Yueda | 3.67 |
| ||
| 000506 | Zhongrun Resources | 4.77 |
| ||
| 000638 | Vanfund Urban | 6.03 |
| ||
| 600864 | Harbin Hatou | 6.17 |
|
Complementary Tools for Tinavi Stock analysis
When running Tinavi Medical's price analysis, check to measure Tinavi Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tinavi Medical is operating at the current time. Most of Tinavi Medical's value examination focuses on studying past and present price action to predict the probability of Tinavi Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tinavi Medical's price. Additionally, you may evaluate how the addition of Tinavi Medical to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |